Mark E. Lutes
Is CMS Ignoring the Realities of Biopharmaceutical Costs?
Health Care and Life Sciences ·
The Scope of Payment Reform Challenges Congress, Providers and Investors
Health Care and Life Sciences ·
The Scope of Payment Reform Challenges Congress, Providers and Investors
Government and Public Policy ·
Bending the Curve Requires Changing the Fuel Mix
Health Care and Life Sciences ·
Bending the Curve Requires Changing the Fuel Mix
Government and Public Policy ·